Related Experiment Video
Updated: Jul 17, 2026

Mouse Models of Periventricular Leukomalacia
Published on: May 18, 2010
Maturation-dependent vulnerability of perinatal white matter in premature birth
Stephen A Back1, Art Riddle, Melissa M McClure
1Department of Pediatrics, Oregon Health & Science University, Portland, OR 97239-3098, USA. Backs@ohsu.edu
Insights
Premature birth survivors are prone to brain injury, particularly periventricular white matter injury (PWMI). Protecting oligodendrocyte progenitors is key to preventing this common cause of long-term neurological issues in preterm infants.
Area of Science:
- Neuroscience
- Neonatalogy
- Developmental Biology
Background:
- Premature birth survivors frequently experience perinatal brain injury, primarily affecting periventricular cerebral white matter.
- Periventricular white matter injury (PWMI) is the leading cause of brain damage and chronic neurological morbidity in preterm infants.
- While cystic lesions (periventricular leukomalacia) decrease, non-cystic focal or diffuse injuries are increasingly prevalent.
Purpose of the Study:
- To investigate the pathogenesis of periventricular white matter injury (PWMI) in preterm infants.
- To identify key cellular targets for preventing brain injury in premature neonates.
- To understand the role of oligodendrocyte progenitors in PWMI development.
Main Methods:
- Review of recent neuroimaging studies on PWMI incidence and lesion types.
- Analysis of experimental data on the mechanisms of ischemic cerebral white matter injury.
- Examination of the developmental biology of oligodendrocyte lineage cells in the context of prematurity.
Main Results:
- PWMI pathogenesis involves cerebral blood flow perturbations and free radical-mediated injury.
- Immature oligodendrocyte progenitors are particularly susceptible to injury during prematurity.
- Oligodendrocyte progenitor injury disrupts myelin formation, contributing to PWMI.
- Ischemia is necessary but not sufficient for PWMI initiation.
Conclusions:
- Oligodendrocyte progenitors are a critical target for preventing PWMI in preterm infants.
- Understanding the cellular and molecular mechanisms of PWMI is advancing rapidly.
- Preventive strategies should focus on protecting these vulnerable cells to reduce long-term neurological deficits.
Abstract:
Survivors of premature birth have a predilection for perinatal brain injury, especially to periventricular cerebral white matter. Periventricular white matter injury (PWMI) is now the most common cause of brain injury in preterm infants and the leading cause of chronic neurological morbidity. The spectrum of chronic PWMI includes focal cystic necrotic lesions (periventricular leukomalacia) and diffuse myelination disturbances. Recent neuroimaging studies support that the incidence of periventricular leukomalacia is declining, whereas focal or diffuse noncystic injury is emerging as the predominant lesion. In a significant number of infants, PWMI appears to be initiated by perturbations in cerebral blood flow that reflect anatomic and physiological immaturity of the vasculature. Ischemic cerebral white matter is susceptible to pronounced free radical-mediated injury that particularly targets immature stages of the oligodendrocyte lineage. Emerging experimental data supports that pronounced ischemia in the periventricular white matter is necessary but not sufficient to generate the initial injury that leads to PWMI. The developmental predilection for PWMI to occur during prematurity appears to be related to both the timing of appearance and regional distribution of susceptible oligodendrocyte progenitors. Injury to oligodendrocyte progenitors may contribute to the pathogenesis of PWMI by disrupting the maturation of myelin-forming oligodendrocytes. There has been substantial recent progress in the understanding of the cellular and molecular pathogenesis of PWMI. The oligodendrocyte progenitor is a key target for preventive strategies to reduce ischemic cerebral white matter injury in premature infants.
Related Concept Videos
Neurulation
Cerebral Edema ll: Pathophysiology

